IQVIA Holdings ROA 2011-2025 | IQV
Current and historical return on assets (ROA) values for IQVIA Holdings (IQV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| IQVIA Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $1.33B | $27.32B | 4.95% |
| 2024-12-31 | $1.37B | $26.90B | 5.13% |
| 2024-09-30 | $1.41B | $27.18B | 5.26% |
| 2024-06-30 | $1.42B | $26.40B | 5.39% |
| 2024-03-31 | $1.36B | $26.57B | 5.16% |
| 2023-12-31 | $1.36B | $26.68B | 5.20% |
| 2023-09-30 | $1.12B | $25.98B | 4.33% |
| 2023-06-30 | $1.10B | $26.04B | 4.33% |
| 2023-03-31 | $1.06B | $25.74B | 4.23% |
| 2022-12-31 | $1.09B | $25.34B | 4.41% |
| 2022-09-30 | $1.18B | $24.22B | 4.81% |
| 2022-06-30 | $1.16B | $24.41B | 4.73% |
| 2022-03-31 | $1.08B | $24.97B | 4.42% |
| 2021-12-31 | $0.97B | $24.69B | 3.98% |
| 2021-09-30 | $0.77B | $24.03B | 3.16% |
| 2021-06-30 | $0.61B | $23.94B | 2.51% |
| 2021-03-31 | $0.41B | $24.47B | 1.70% |
| 2020-12-31 | $0.28B | $24.56B | 1.18% |
| 2020-09-30 | $0.18B | $23.84B | 0.75% |
| 2020-06-30 | $0.13B | $23.18B | 0.57% |
| 2020-03-31 | $0.22B | $23.08B | 0.93% |
| 2019-12-31 | $0.19B | $23.25B | 0.83% |
| 2019-09-30 | $0.24B | $22.89B | 1.07% |
| 2019-06-30 | $0.25B | $23.07B | 1.08% |
| 2019-03-31 | $0.25B | $23.11B | 1.09% |
| 2018-12-31 | $0.26B | $22.55B | 1.14% |
| 2018-09-30 | $1.22B | $22.50B | 5.34% |
| 2018-06-30 | $1.25B | $22.63B | 5.46% |
| 2018-03-31 | $1.25B | $23.24B | 5.52% |
| 2017-12-31 | $1.28B | $22.86B | 5.79% |
| 2017-09-30 | $0.03B | $22.45B | 0.13% |
| 2017-06-30 | $0.04B | $21.78B | 0.24% |
| 2017-03-31 | $0.07B | $21.18B | 0.52% |
| 2016-12-31 | $0.07B | $21.21B | 0.87% |
| 2016-09-30 | $0.40B | $4.13B | 9.92% |
| 2016-06-30 | $0.41B | $3.96B | 10.26% |
| 2016-03-31 | $0.41B | $3.98B | 10.65% |
| 2015-12-31 | $0.39B | $3.93B | 10.62% |
| 2015-09-30 | $0.37B | $4.03B | 10.67% |
| 2015-06-30 | $0.35B | $3.34B | 10.88% |
| 2015-03-31 | $0.35B | $3.24B | 11.19% |
| 2014-12-31 | $0.36B | $3.30B | 11.48% |
| 2014-09-30 | $0.34B | $3.11B | 11.17% |
| 2014-06-30 | $0.32B | $2.98B | 10.54% |
| 2014-03-31 | $0.27B | $3.06B | 9.26% |
| 2013-12-31 | $0.23B | $3.07B | 8.27% |
| 2013-09-30 | $0.19B | $2.84B | 7.26% |
| 2013-06-30 | $0.17B | $2.65B | 9.19% |
| 2013-03-31 | $0.18B | $2.43B | 14.78% |
| 2012-12-31 | $0.18B | $2.50B | 28.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $25.076B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.696B | 87.47 |
| Thermo Fisher Scientific (TMO) | United States | $156.188B | 18.89 |
| Edwards Lifesciences (EW) | United States | $45.655B | 29.93 |
| Alcon (ALC) | Switzerland | $43.440B | 29.36 |
| IDEXX Laboratories (IDXX) | United States | $41.591B | 47.80 |
| DexCom (DXCM) | United States | $34.247B | 52.93 |
| Mettler-Toledo (MTD) | United States | $24.648B | 29.31 |
| STERIS (STE) | Ireland | $24.609B | 27.14 |
| Waters (WAT) | United States | $21.548B | 30.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.213B | 0.00 |
| Hologic (HOLX) | United States | $12.584B | 13.67 |
| Penumbra (PEN) | United States | $10.887B | 85.45 |
| Sysmex ADR (SSMXY) | Japan | $10.571B | 29.99 |
| Globus Medical (GMED) | United States | $8.473B | 19.87 |
| Masimo (MASI) | United States | $8.467B | 31.23 |
| Teleflex (TFX) | United States | $5.606B | 9.25 |
| Glaukos (GKOS) | United States | $5.571B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.243B | 22.23 |
| TransMedics (TMDX) | United States | $4.218B | 91.70 |
| PROCEPT BioRobotics (PRCT) | United States | $3.274B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.447B | 14.57 |
| Veracyte (VCYT) | United States | $2.256B | 31.66 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.058B | 23.60 |
| Alphatec Holdings (ATEC) | United States | $1.896B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.567B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.68 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.035B | 5.50 |
| SiBone (SIBN) | United States | $0.840B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| IRadimed (IRMD) | United States | $0.678B | 34.38 |
| RxSight (RXST) | United States | $0.675B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.627B | 13.70 |
| Delcath Systems (DCTH) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| NeuroPace (NPCE) | United States | $0.590B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| AxoGen (AXGN) | United States | $0.527B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.468B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| Treace Medical Concepts (TMCI) | United States | $0.421B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.386B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.229B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.122B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.099B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EDAP TMS S.A (EDAP) | France | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 17.08 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |